PE Tech Report


Like this article?

Sign up to our free newsletter

Runway Growth Capital adds two MDs to team

Runway Growth Capital (Runway), a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, has appointed Ted Cavan as Managing Director, Technology, and Brannon Morisoli as Managing Director, Life Sciences.

Cavan will operate out of Boston and report directly to Founder, Chief Executive Officer, and Chief Investment Officer, David Spreng. As a member of Runway’s origination team, Cavan will engage with a broad array of late and growth-stage technology companies, focusing on enterprise software. He brings to Runway a decade of experience helping businesses advance their goals using venture and growth debt.

Operating out of Dallas, meanwhile, and reporting directly to Life Sciences Managing Director, Igor DaCruz, Morisoli will focus on investments in the life sciences industry, structuring flexible debt capital solutions for borrowers that will enable them to stay focused on achieving their business goals. Morisoli aims to continue building relationships with leading venture capital firms that support top management teams in life sciences, while expanding the firm’s banking and broker relationships.

Cavan most recently held the position of Senior Vice President at Stifel, where he led the Boston area technology practice of its Venture Banking and Lending Group. In his role, Cavan was responsible for sourcing promising investment opportunities, building relationships with management teams, crafting deal terms, and actively managing a portfolio of senior debt investments ranging from $1million to $50 million. He previously worked for TriplePoint Capital as a Vice President, where he became Principal and was part of a two-person team responsible for launching TriplePoint’s East Coast efforts in 2015. Prior to that, he was a Vice President at Square 1 Bank, responsible for origination, due diligence, deal execution, and portfolio management of more than $150 million of loans ranging from $250k–$20 million.

Before Runway, Morisoli was a Director at SWK Holdings, where he focused on providing innovative capital solutions to a broad range of healthcare and life science companies. Prior to joining SWK, Morisoli was an Investment Analyst for Presidium Group, where he played an integral role in closing over $100 million in transactions for the real estate private equity firm. Morisoli has an excellent working knowledge of the life sciences and medical devices space, having started his career as a research associate where he was published in leading neurology journals. After that, he gained broad operational experience while serving as the Marketing Services Manager at Neurografix, a venture backed medtech startup.

Like this article? Sign up to our free newsletter